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Recent guidelines share the recommendations that psychotherapy plays a central role in
the treatment of borderline personality disorder (BPD). In recent years, interpersonal
psychotherapy adapted for treating BPD (IPT-BPD) was added to specific
psychotherapies and was tested in combination with pharmacotherapy. The present
study is aimed to assess the efficacy of IPT-BPD revised (IPT-BPD-R) as single treatment
in a sample of BPD patients. Results obtained in a group of patients receiving IPT-BPD-R
were compared with those observed in a control group in waiting list plus clinical
management (WL/CM). Forty-three BPD subjects were randomly allocated to one of
the two arms. Patients were assessed at baseline and after 10 months with the following
assessment instruments: Clinical Global Impression Scale, Severity item (CGI-S), Social
Occupational Functioning Assessment Scale (SOFAS), Borderline Personality Disorder
Severity Index (BPDSI), Barratt Impulsiveness Scale, version 11 (BIS-11), Modified Overt
Aggression Scale (MOAS), and Self Harm Inventory (SHI). Statistical analysis was
performed with one-way analysis of variance (ANOVA) or chi-square test to compare
baseline characteristics of the two treatment groups. Comparison of score changes at
the end of the trial between the two groups was calculated for each rating scale with the
analysis of variance for repeated measures. Seven patients (16.3%) discontinued the
treatment in the first month of the trial for non-adherence. We found a significant effect
within subjects (trial duration) for all rating scales, except for the MOAS. A significant effect
between subjects (treatment modality) was found for CGI-S; SOFAS; BIS-11 total score
and subscale “non-planning impulsivity”; BPDSI total score and items “interpersonal
relationships,” “impulsivity,” and “identity.” So, results showed differences between
groups in favor of psychotherapy in terms of reduction of severity of general
psychopathology, improvement of social and occupational functioning, and decrease of
global BPD symptoms and three specific domains. On the other hand, we did not find any
differences between groups for self-harm behaviors and aggressive behaviors.
Keywords: interpersonal psychotherapy (IPT), borderline personality disorder (BPD), waiting list, controlled trial,
time-limited psychotherapyg September 2020 | Volume 11 | Article 5789101
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Borderline personality disorder (BPD) is a heterogeneous and
severe psychiatric disorder, characterized by a pervasive
instability in affects, impulse, sense of self, and interpersonal
relationships. BPD reaches a point prevalence rate of 2.7% (1)
and represents the most common personality disorder in clinical
populations (2, 3). Because of the complexity of the disorder several
sets of guidelines for the treatmentofBPDwere published in the last
two decades, but no medication has obtained an official indication
for it, yet. Recent guidelines from the National Institute for Health
andClinical Excellence of England andWales (NICE) (4, 5) and the
National Health and Medical Research Council (NHMRC) of the
Australian Government (6) concluded that drug therapy was not
recommendedother than for treatment of othermental disorders in
comorbidity or to control, duringa crisis or a limitedperiod, specific
acute symptoms (7). Systematic reviews, meta-analyses, and
guidelines share the opinion that psychotherapy plays a central
role in BPD treatment (8–10). Several models of psychotherapy
specifically developed for this disorder have been tested in single or
combined trials (11–13).Among themost notable interventions are
dialectical behavior therapy (DBT) (14) mentalization-based
therapy (MBT) (15), and transference focused therapy (TFP)
(16). In recent years, interpersonal psychotherapy was adapted
for treating BPD patients (IPT-BPD) and was presented as an
addition to the available therapeutic tools (17–22). IPT adapted for
BPD derived from the standard model of IPT for major depression
(23) modified byMarkowitz (17) to address the peculiar features of
BPD and to handle the difficulties in interpersonal relationships
typical of these patients. Our research group proposed a revision of
the IPT-BPD that is indicated as IPT-BPD-R (24).
With the purpose to begin studying the efficacy of this new
proposal of psychotherapy we performed initial trials in samples of
BPD patients who received a combination of IPT-BPD with
medications commonly used in this clinical population (19–22).
Results showed that combined treatment with IPT-BPD and
fluoxetine was superior to single fluoxetine to treat three BPD
core symptoms: disturbed interpersonal relationships, affective
instability, and impulsive dyscontrol. It was also more effective
to decrease severity of anxiety symptoms and to improve the
subjective perception of quality of life (19). The increased effects of
combined therapy on impulsivity, interpersonal dysfunctions, and
quality of life were maintained during 2 years of follow-up (22).
The present pilot study is the first trial that was designed to
assess the efficacy of our revision of IPT-BPD as single treatment of
a sample of BPD patients. Results obtained in patients receiving
IPT-BPD-R were compared with those observed in a control group
of patients in waiting list plus clinical management (WL/CM).MATERIALS AND METHODS
Participants
Forty-three consecutive outpatients with a diagnosis of BPD
according with Diagnostic and Statistical Manual of Mental
Disorders, 5th Edition (DSM-5) criteria (25) were recruited forFrontiers in Psychiatry | www.frontiersin.org 2this study. All participants were aged between 18 and 60 years.
Patients attended the Center for Personality Disorders of the
Department of Neuroscience at the University of Turin, Italy.
The psychiatric diagnosis was made by an expert clinician and
was confirmed with the Structured Clinical Interview for
DSM 5 Clinical Version and Personality Disorders (26, 27).
Exclusion criteria were: 1) a diagnosis of dementia or other
cognitive disorders, schizophrenia or other psychotic disorders,
or bipolar disorders, 2) a co-occurring major depressive
episode and/or substance abuse, and 3) the administration of
psychotropic medications and/or psychotherapy in the 3 months
preceding the beginning of the study. Female patients of
childbearing age were excluded if they were not using adequate
birth control methods. This exclusion criterion was needed as
patients in this sample were also evaluated before and after
treatment with functional magnetic resonance. Patients were re-
assessed at the end of the study to investigate if they still fulfilled
DSM-5 diagnostic criteria for BPD. Assessment was made
considering a time period of 1 month.
The group of 43 BPD subjects was randomly allocated to: 1)
IPT-BPD-R (N = 22 patients) or 2) WL/CM (N = 21 patients).
Research Randomizer (Urbaniak and Plous, Social Psychology
Network Wesleyan University, Middletown, CT), a free web-
based service for randomization, was used.
The 22 patients who received IPT-BPD-R and the 21 patients
who were in WL/CM are matched for gender, age, and education
(number of years completed at school and university referred by
patients and confirmed by school and academic certificates).
Psychotherapy was provided by therapists who were certificated
by the Italian Society for Interpersonal Psychotherapy according to
the international guidelines for IPT training and had at least 5 years
of experience practicing IPT-BPD. Sessions of psychotherapy were
steadily supervised by a senior psychotherapist (S.B.) with
particular attention to check for fidelity to the manual.
Each subject voluntarily participated in the study, after
providing written informed consent. We observed the
Declaration of Helsinki guidelines. Approval was obtained from
the ethics committee of the University Hospital “Città della Salute
e della Scienza—Ospedale dell’Ordine Mauriziano” of Turin. The
trial was registered as a part of a study of functional neuroimaging
in the Australian New Zealand Clinical Trials Registry (ANZCTR)
and allocated the code: ACTRN12619000078156.
Measures
Patients were assessed at baseline and after 10 months with the
following assessment instruments:
1. The Clinical Global Impression Scale, Severity item (CGI-S)
(28),
2. The Social Occupational Functioning Assessment Scale
(SOFAS) (29),
3. The Borderline Personality Disorder Severity Index (BPDSI)
(30),
4. The Barratt Impulsiveness Scale, version 11 (BIS-11) (31),
5. The Modified Overt Aggression Scale (MOAS) (32),
6. The Self Harm Inventory (SHI) (33).September 2020 | Volume 11 | Article 578910
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assessment of illness and consists of three different measures:
severity of illness, global improvement, and efficacy index. In this
study we considered severity of illness. It is a seven-point scale
ranging from 1 (normal) to 7 (extremely ill).
The BPDSI is a semi-structured clinical interview assessing
frequency and severity of BPD related symptoms. The interview
consists of eight items scored on a 10-point frequency scale (0 =
never; 10 = daily), including “abandonment,” “inter-personal
relationships,” “impulsivity,” “para-suicidal behavior,” “affective
instability,” “emptiness,” “outbursts of anger,” “dissociation and
paranoid ideation,” and of one item scored on a four-point
severity scale, concerning “identity.” The BPDSI showed
adequate reliability and construct validity also in the Italian
version (34).
The BIS-11 is a 30-items self-report questionnaire measuring
the trait of impulsivity on a 4-point Likert scale. Higher scores for
each item indicate higher levels of impulsivity. Twelve items are
reverse-scored, in order to avoid response sets. Is it possible to
identify three factors: cognitive impulsivity, motor impulsivity,
and non-planning impulsivity. Global score is obtained by the
sum of these factors. The BIS-11 showed adequate reliability and
construct validity in both USA (35) and Italian (36) samples.
The MOAS is a clinician-rated scale consisting of four
subscales for different types of aggression (verbal aggression,
aggression against objects, aggression against others, and self-
aggression). The subscales are rated on a 5-point scale (score 0–
4). Higher scores for each subscale reflect the higher severity of a
subject’s aggressiveness (32, 37).
The SHI is a brief, self-reporting instrument that provides
informative data about clinically-relevant self-harm behaviors.
Although not considered in the scoring, many of the SHI items
provide additional information regarding the number of times a
patient engages in a self-destructive act, as well as how recently
he or she has done so. The scoring of the instrument is easily
determined by counting the number of self-harm behaviors (38).
Assessment was performed by an investigator (P.B.) who
received training session on psychometric instruments prior to
start investigation.
At the end of the trial we also assessed how many patients still
fulfilled diagnostic criteria for BPD. Clinical assessment was
performed and Structured Clinical Interview for DSM-5
Disorders (SCID-5)-PD was re-administered.
Treatment Conditions
Interpersonal Psychotherapy Adapted for Borderline
Personality Disorder—Revised
IPT was initially developed by Klerman in 1984 (23) to treat major
depression, but some investigators have successfully extended its
indications to other psychiatric disorders (17, 39–45). Markowitz
(17, 18) proposed an adaptation of IPT to the treatment of patients
with BPD. IPT-BPD departs from the standard acute treatment of
major depression to suit the needs of this particular and severe
population of patients. Features of adaptation involve: different
conceptualization of the disorder (BPD is defined as a mood-
inflicted chronic illness similar to dysthymic disorder but withFrontiers in Psychiatry | www.frontiersin.org 3sporadic outbursts of anger); prolonged length of treatment (a first
acute phase of 18 IPT sessions and a continuation phase of 16
sessions, up to 34 IPT sessions over 8 months); and flexibility of
setting (a 10-min telephone contact once a week is provided) to
handle crises and minimize the risk of therapeutic ruptures. In the
last years, we designed a proposal of revision (IPT-BPD-R) of
Markowitz’s adaptation of IPT to BPD in the attempt to overcome
some limitations of this model that emerged during clinical
practice. IPT-BPD-R consists of 10 months of therapy divided
into two phases of 22 sessions (20 weeks) and 20 sessions (20
weeks). Sessions duration is of 50 min. Three additional sessions
can be provided if patients present serious difficulties during the
termination phase. Two weekly contacts by phone with the
therapist are allowed in situations of crisis, as well as two
admissions to hospital for a brief period of 7–10 days. During
the hospitalization IPT-BPD-R continues if the patient’s clinical
conditions allow it. In our revised model of IPT-BPD is also
included an intervention for patients’ family members in order to
help them to understand and deal with the disorder of their
relative (24).
Waiting List and Clinical Management
BPD patients who did not receive psychotherapy were monitored
with 50-min clinical visits (assessment of symptoms and
supportive intervention) with a frequency of once monthly. No
medications were administered in this group.
Statistics
Statistical analysis was performed with one-way analysis of
variance (ANOVA) or chi-square test to compare baseline
characteristics of the two treatment groups (age, gender, level
of education, and clinical and functional rating scales scores).
Comparison of score changes at the end of the trial between the
two groups was calculated for each rating scale with the analysis
of variance for repeated measures.
The software IBM SPSS Statistics version 26 (IBM Corp, 1989,
2019) was used for the analyses.
P values were considered significant when ≤ 0.05.RESULTS
Forty-three patients were randomly assigned to 1) IPT-BPD-R
(N=22) or to 2)WL/CM (N=21). Thirty-six out of the 43 patients
(83.7%) completed the 10 months of the trial: 19 patients (52.7%
of the completers) received IPT-BPD-R, while 17 patients
(47.2%) was in WL/CM. Seven patients of the recruited sample
(16.3%) discontinued the treatment in the first month of the trial
for non-adherence to study protocol: three in the group who
received IPT-BPD-R and four in the group in WL/CM. The final
sample resulted in 36 patients with the mean age of 35.42 ± 14.71
years; they were 13 females (68.4%) and 6 males in IPT-BPD-R
group and 11 females (64.7%) and 6 males in WL/CM group. No
differences between the two groups were found concerning age,
gender, and level of education with the ANOVA and chi
square test.September 2020 | Volume 11 | Article 578910
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rating scales are reported in Tables 1 and 2. No significant
differences between groups were found at baseline between the
two treatment arms.
Results of the ANOVA for repeated measures to evaluate the
effect of trial duration (within-subjects effect) and of treatment
modality (between-subjects effect) on the score changes after 10
months are reported in Table 3.
We found a significant effect within subjects (trial duration)
for all rating scales (P values ranged between 0.001 and 0.032),
except for the MOAS (P = 0.12).
A significant effect between subjects (treatment modality) was
found for CGI-S (P = 0.009); for SOFAS (P = 0.02); for BIS-11
total score (P = 0.031) and subscale “non-planning impulsivity”
(P = 0.042); for BPDSI total score (P = 0.01) and items
“interpersonal relationships” (P = 0.001), “impulsivity” (P =
0.03), “identity” (P = 0.014).Frontiers in Psychiatry | www.frontiersin.org 4DSM-5 diagnostic criteria for BPD were still met by the 36
patients who completed the trial.DISCUSSION
The present randomized controlled trial is to our knowledge
the first study that specifically investigated the efficacy of
interpersonal psychotherapy adapted for borderline personality
disorder as single therapy in comparison with waiting list and
clinical management in a group of moderately ill patients with a
DSM-5 diagnosis of BPD. Previous studies found that IPT may
be considered a useful treatment tool for these patients, who
show prominent relational problems, but the majority of data
derived from trials that used IPT-BPD in combination with
medications (18–22).
All subjects in this sample still fulfilled DSM-5 diagnostic
criteria for BPD at the end of the trial. A possible reason of this
finding is that a time-limited psychotherapy has a significant
effect in decreasing severity of BPD symptoms and improving
global functioning, but it does not produce such a change of
personality organization to obtain a full remission of the
disorder. We assessed the diagnosis of BPD at the end of trial
considering a time period of 1 month. In our opinion, this
period is appropriate to measure changes after a time-limited
psychotherapy, in accordance with previous studies of short-
term therapies of BPD (46).
An interesting result of this study is that both groups of
patients and controls obtained a significant improvement in all
outcome measures after 10 months of observation, except for the
measure of aggressive behaviors that did not significantly change
in the two arms. This finding suggested that in BPD taking
charge of the patient may contribute by itself to induce a clinical
and functional improvement, independently by the specificity of
the therapy. Concerning aggressive behaviors, in this study we
found that neither interventions (IPT and WL/CM) obtained a
significant improvement. A possible explanation is that in our
sample MOAS scores at baseline were rather low (with a mean
lower than 5).
Results of the ANOVA also showed differences between
groups in favor of psychotherapy in terms of reduction of
severity of general psychopathology, improvement of social
and occupational functioning, and decrease of global BPD
symptoms and specific domains. In particular, patients who
received IPT-BPD-R presented a greater improvement on
impulsive behavioral dyscontrol, interpersonal disturbance, and
identity diffusion in comparison with patients in WL/CM. On
the other hand, we did not find any differences between groups
on self-harm behaviors and aggressive behaviors.
In previous investigations of our research group, we observed
that the addition of IPT-BPD to medication produced greater
effects on some BPD core symptoms, as impulsive dyscontrol
and interpersonal relationships disturbance with advantages that
endured during a follow-up period of 2 years (19, 22). In the
present study these results were confirmed in patients who
received IPT-BPD-R as single treatment. So, we can suppose
that the improvement of impulsive behaviors and interpersonalTABLE 1 | Comparison of the baseline values of symptoms and functioning
rating scales between the Interpersonal Psychotherapy Adapted to Borderline






CGI-S 4.00 ± 0.82 4.20 ± 0.79 0.584
BIS-11 total score 80.22 ± 9.30 81.13 ± 5.96 0.337
BIS-11 non-planning 26.41 ± 4.53 26.72 ± 5.01 0.682
BIS-11 motor 30.74 ± 6.23 31.04 ± 6.11 0.682
BIS-11 attentive 22.57 ± 5.44 21. 87± 6.75 0.263
MOAS 4.50 ± 2.61 4.20 ± 3.11 0.620
SHI 7.80 ± 4.02 7.33 ± 2.27 0.454
SOFAS 57.10 ± 7.06 55.50 ± 9.27 0.167SD, standard deviation; ANOVA, analysis of variance; CGI-S, Clinical Global Impression
scale—Severity item; SOFAS, Social Occupational Functioning Assessment Scale; BIS-
11, Barrett Impulsiveness Scale—version 11; MOAS, Modified Overt Aggression Scale;
SHI, Self Harm Inventory; IPT-BPD-R, Interpersonal Psychotherapy Adapted to Borderline
Personality Disorder-Revised; WL/CM, waiting list plus clinical management.TABLE 2 | Comparison of baseline values of Borderline Personality Disorder
Severity Index (BPDSI) total score and single items between the Interpersonal
Psychotherapy Adapted to Borderline Personality Disorder-Revised (IPT-BPD-R)






BPDSI total score 48.09 ± 5.85 47.45 ± 6.32 0.630
Abandonment 7.32 ± 1.15 7.54 ± 1.32 0.321
Interpersonal
relationships
8.01 ± 0.27 7.31 ± 1.82 0.413
Identity 2.28 ± 1.14 2.31 ± 1.29 0.403
Impulsivity 7.12 ± 1.31 6.92 ± 1.73 0.332
Parasuicidal
behaviors
1.30 ± 1.50 1.42 ± 1.30 0.237
Affective instability 7.52 ± 0.89 6.84 ± 1.05 0.276
Outbursts of anger 6.30 ± 1.55 6.88 ± 1.43 0.327
Emptiness 5.60 ± 1.05 4.82 ± 1.34 0.182
Dissociation/
paranoid ideation
2.38 ± 1.89 2.59 ± 1.82 0.562SD, standard deviation; ANOVA, analysis of variance; BPDSI, Borderline Personality
Disorder Severity Index; IPT-BPD-R, Interpersonal Psychotherapy Adapted to
Borderline Personality Disorder-Revised; WL/CM, waiting list plus clinical management.September 2020 | Volume 11 | Article 578910
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interpersonal psychotherapy. In fact, IPT-BPD is a model of
psychotherapy that is aimed to improve BPD psychopathology
by a modification of dysfunctional interpersonal patterns. Better
abilities to organize interpersonal relationships obtained with
this therapy are expected to promote a more stable social
environment with consequently a more successful control of
impulsive reactions.
When we compared our results with those drawn by studies
that evaluated the efficacy of other models of psychotherapy,
such as DBT, MBT, and TFP, we found some overlapping effects,
but also differences among the four treatment models. For
example, the greater effect of IPT versus WL/CM on general
psychopathology and global functioning found in the
present study is shared by DBT (47, 48), MBT (49), and
TFP (50, 51) in comparison with treatment as usual or
general clinical management. It is not particularly surprising
that general psychiatric symptoms and functioning improve
with psychotherapy independently of the specific design
of intervention, but it is noticeable that these improvements
derived by specific psychotherapies rather than general
supportive treatments.
Considering the core BPD symptoms, a result that is
particularly worthy of attention concerns the effect of IPT-BPD-
R in regulating self- and hetero- evaluated impulsivity. We found
that non-planning impulsivity, typical of BPD subjects, is
particularly sensitive to the IPT intervention. As far as we know,
no other studies on the efficacy of psychotherapy in BPD obtained
the same finding, except for our previous study of IPT-BPD
combined with medication and a single trial that indicated a
small effect of DBT on impulsivity in BPD patients (52). So, we canFrontiers in Psychiatry | www.frontiersin.org 5hypothesize that the effect of IPT-BPD on impulsive symptoms is
rather specific for this model of psychotherapy.
On the contrary, several trials conducted on DBT registered a
significant reduction of self-harm behaviors that was not
observed in our sample. We can suggest that DBT is specific in
reducing self-aggressive behaviors that commonly occur in
patients with BPD (8, 14, 48, 52, 53).
In our investigation, disturbance of interpersonal relationships
showed a better improvement in patients treated with IPT-BPD-R
compared with controls. Similar findings were reported in two
studies performed on the efficacy of MBT in partially-hospitalized
BPDpatients (15) and in BPD outpatients (49). The common effect
of IPT and MBT in restoring interpersonal relationships of BPD
patients can be due to the fact that both psychotherapies, with
different techniques, are aimed to ameliorate the reflective function
of these patients and their abilities to understand thoughts and
emotions of others.
Another remarkable result of our trial concerns the effect of
IPT-BPD-R on identity disturbance. We observed that patients
who received IPT-BPD-R showed a greater reinforcement of
identity integration than patients in WL/CM. In accordance
with our finding, some authors observed that time-limited
psychotherapy (in particular data concerned dialectical
behavior psychotherapy) can improve identity disturbance in
patients affected by BPD enhancing the patient’s sense of self and
coherence in their feelings and thoughts (54–56).
The incapacity to maintain a stable and cohesive sense of self
in BPD patients involves a precarious and troubled world view in
the context of interpersonal interactions. So, a model of
psychotherapy focused on interpersonal problems, like IPT,
encourages the person to establish more balanced, realistic, andTABLE 3 | Significant results of the ANOVA for repeated measures calculated in the completers to compare the changes of the Clinical Global Impression Scale,
Severity item (CGI-S), Social Occupational Functioning Assessment Scale (SOFAS), Barratt Impulsiveness Scale, version 11 (BIS-11) total score and “non-planning
impulsivity” subscale, Borderline Personality Disorder Severity Index (BPDSI) total score and items “impulsivity,” “interpersonal relationships,” and “identity diffusion”
scores, and Self Harm Inventory (SHI) score between treatment groups.
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self (21).
However, this result requires to be considered with caution
and needs to be replicated to draw any reliable conclusions. In
fact, we only found a significant score change of the item
“identity disturbance” of the BPDSI, but we did not assess the
level of identity integration with specific evaluation instruments.
The present study presented some points of strength, such as
the randomized controlled design, and the use of both self-
evaluated and clinician-rated instruments to obtain a more
reliable assessment.
Moreover, patients who completed the trial were 83.7% of the
initial sample, which can be considered a very good proportion
in a sample of BPD patients.
On the other hand, ourfindings are affected by some limitations.
The first limit concerns the relatively small size of the clinical
sample. A second limitation is possibly due to the exclusion of
psychiatric comorbidities. In fact, this choice has the relevant
purpose to avoid the effects of coexisting psychiatric disorders on
treatment response, but has the unfavorable consequence that
clinical characteristics of our patients are partly different from
those found in clinical practice and can limit generalizability of
our findings. So, this is a relevant issue in choosing selection criteria
ofBPDpatients for clinical trials. Another limitwas that assessment
instruments did not include a scale designed to evaluate the specific
mechanisms of action of IPT-BPD.
In summary, our pilot trial is aimed to test the efficacy of IPT-
BPD-R as single therapy of BPD patients. Subjects treated with
this psychotherapy showed a greater improvement in general
psychopathology, social and occupational functioning, and
global and specific BPD symptoms (impulsive behavioral
dyscontrol, interpersonal disturbance, and identity diffusion) in
comparison with control patients in WL/CM.
On the basis of our data and those derived from studies that
were performed to assess the efficacy of other psychotherapeutic
interventions, we can conclude that the main psychotherapies
available for BPD patients produce comparable effects onFrontiers in Psychiatry | www.frontiersin.org 6general psychopathology and global functioning, but different
models seem to be targeted on specific symptoms domains. IPT-
BPD-R appeared to induce a more specific effect on impulsive
dyscontrol, interpersonal relationships, and identity disturbance.
However, these are initial results that need to be replicated before
considering their implementation in clinical practice.DATA AVAILABILITY STATEMENT
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